124 results
Page 2 of 7
6-K
EX-99.1
mblf3d
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
egwd37 12hnfmd5t9mko
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
m26lapk5
30 May 23
Current report (foreign)
6:11am
6-K
cc5stjj2ngqy73
11 May 23
Current report (foreign)
6:07am
6-K
c8ivvboob72cjmqm6t6
30 Mar 23
Current report (foreign)
6:19am
6-K
EX-99.1
ujhai02ay jcqfwp1owm
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
37wrnar
30 Nov 22
Current report (foreign)
6:28am
6-K
lp2su3rx
4 Nov 22
Current report (foreign)
6:01am
6-K
02kbyfc
4 Aug 22
Current report (foreign)
6:07am
6-K
ggdwibl2 006eqwu
11 Jul 22
Current report (foreign)
6:05am
6-K
0o2 w9zy2p3eta
10 Jun 22
Current report (foreign)
6:00am
6-K
rwrke
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
6k51dl38pw bgba
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
vcmobfvq3vezpctuu
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
ql041bg
31 May 22
Current report (foreign)
12:00am
6-K
i6xr 0ydd
11 May 22
Current report (foreign)
6:06am
6-K
tq7j pb7w1odczl4e
10 Feb 22
Current report (foreign)
6:03am
6-K
l05xjfo uu0fc3
11 Jan 22
Current report (foreign)
6:04am
6-K
EX-99.1
ga3ucqndpx2kd2t
11 Jan 22
Current report (foreign)
6:02am